Adrenomedullin (ADM), a ubiquitous vasoactive peptide, has been the target of a multitude of studies concerning its effect on the vascular tone. The present work aims at clarifying a series of its interactions with the renin-angiotensin system.
The study uses the rat aorta ring as a model of conductance vessels, with or without vascular endothelium, and the second order branch of rat mesenteric arteries as a model of resistance arteries. Interactions between various concentrations of ADM and angiotensin II (Ang II) were studied, in the presence of L-NAME (a nitric oxide [NO] synthase inhibitor) and methylene blue (MB; a soluble guanylate cyclase inhibitor).
Results point out differences in the mechanism of the inhibitory action of ADM upon Ang II effects in the two vessel types studied. Inhibition of Ang II contraction by ADM involves guanylate cyclase in both cases. However, NO is involved in ADM-induced inhibition of angiotensinergic not in the resistance ones. vasoconstriction only in the conductance arteries, not in the resistance ones.
Kitamura K., Kangawa K., Kawamoto M. et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheocromocytoma. Biochem Biophys Res Commun1993;192:553-60.
2.
Hinson JP, Kapas I., Smith DMAdrenomedullin, a multifunctional regulatory peptide. Endocrine Rev2000; 21:138-67.
3.
Ishimitsu T. , Kojima M., Kangawa K., Hino J., Kitamura K.Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun1994;203:631-9.
4.
Samson WKProadrenomedullin-derived peptides. Front Neuroendocrinol1998;19:100-27.
5.
Poyner D., Sexton PM, Marshall I., Smith DM, Foord SMMammalian calcitonin gene-related peptides, adrenomedullin, amylin and calcitonin receptors. Pharmacol Rev2000 ;54:233-46.
6.
Wangensteen R., Quesada A., Sainz J., Duarte J., Vargas F., Osuna A.Role of endothelium-derived relaxing factors in adrenomedullin induced vasodilation in the rat kidney . Eur J Pharmacol2002;444:97-102.
7.
Eto T., Kitamura K., Kato J.Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol1999;26:371-80.
8.
Shirai M., Shimouchi A., Ikeda S., Kanagawa K., Matsuo H.Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anaesthetized cats. Brit J Pharmacol1997 ;121:679-86.
9.
Barber DA, Park YS, Burnett JC, Miller VMAdrenomedullinmediated relaxations in vein are endothelium-dependent and distinct from arteries. J Cardiovasc Pharmacol1997 ;30:695701.
10.
Chu DQ, Smith DM, Brain SDStudies of the micro vascular effects of adrenomedullin and related peptides . Peptid N es2001;22:1881-6.
11.
Ueta Y., Kitamura K., Isse T., Shibuya I., Kabashima N., Eto T.Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci Lett1995;202:3740.
12.
Ueta Y., Serino R., Shibuya I., Kitamura K., Russell JAA physiological role for adrenomedullin in rats: a potent hypotensive peptide in the hypothalamo-neurohypophysial system. Exp Physiol2000;85S:163-9.
13.
Eguchi S., Hirata Y., Kano H., Sato K., Watanabe Y., Marumo F.Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett1994;340:226-30.
14.
Coppock HA, Owji AA, Bloom SR, Smith DMA rat skeletal muscle cell line expresses specific adrenomedullin binding sites but activates adenylate cyclase via CGRP receptors. Biochem J1996;318:241-5.
15.
Lang MG, Paterno R., Faraci FM, Heistad DDMechanisms of adrenomedullin-induced dilatation of cerebral arterioles . Stroke1997;28:181-5.
16.
Hayakawa H. , HirataY,Kakoki M. et al. Role of nitric oxidecGMP pathway in adrenomedullin-induced vasodilatation in the rat. Hypertension1999 ;33:689-93.
17.
Fujioka H., Okamura I., Toda N.Inhibition by adrenomedullin of amine release from adrenergic nerves in dog mesenteric arteries. Eur J Pharmacol1999;385:155-61.
18.
Berthiaume N., Claing A., Lippton H., Cadieux A., D'Orleans-Just P.Rat adrenomedullin induces a selective arterial vasodilatation via CGRP-1 receptors in the double-perfused mesenteric bed of the rat. Canad J Physiol Pharmacol1995;73: 1080-3.
19.
Samson WK, Resch ZT, Murphy TC, Vargas T., Schell DAAdrenomedullin: is there physiological relevance in the pathology and pharmacology?New Physiol Sci1999;14:255-9.
20.
Ando K., Ito Y., Kumada M., Fujita T.Oxidative stress increases adrenomedullin mRNA levels in cultured rat vascular smooth muscle cells. Hypertens Res Clin Exp1998;21:187-91.
21.
Krzeminski K., Mikulski T., Kruk B., Nazar K.Plasma adrenomedullin response to maximal exercise in healthy subjects. J Physiol Pharmacol2003;54:225-32.
22.
Jensen BL, Kramer BK, Kurtz A.Adrenomedullin stimulates renin release and D renin mRNA in mouse juxtaglomerular granular cells. Hypertension1997;29:1148-58.
23.
Andreis PG , Mazzochi D.G., Rebufatt P., Nussdorfer GGEffects of adrenomedullin and PAMP on rat zona glomerulosa cells. Life Sci1997;60:1693-7 .
24.
Petrie MC, Hillier C., Morton JJ, Mc Murray J.Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. J Hypertens2000;18:61-4.
25.
Eto T., Kato J., Kitamura K.Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regulatory Peptides2003;112:61-9.
26.
Charles CJ, Lainchbury JG, Nicholls MG, Rademacher MT, Troughton RWAdrenomedullin and the renin-angiotensin-aldosterone system. Regulatory Peptides2003;112:41-9.
Abdullah K. , Cawley T., Connolly C., Ruiz E., Docherty JRComparison of the effects of nitric oxide synthase inhibition and guanylate cyclase inhibition on vascular contraction in vitro and in vivo in the rat. Naunyn Schmiedebergs Arch Pharmacol1997;356:481-7.
29.
Mulvany MJ, Halpern W.Mechanical properties of vascular smooth muscle cells in situ. Nature1976;260:617-19.
30.
Haulica I.,Todiras M., Brailoiu E., Baltatu O.Modulatory role of nitric oxide on angiotensins vasoconstriction. Rom J Physiol1996; 33:83-90.
31.
Ignarro LJBiological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res1989;65:1-21.
